Serum calcitonin precursors in sepsis and systemic inflammation

被引:155
作者
Whang, KT
Steinwald, PM
White, JC
Nylen, ES
Snider, RH
Simon, GL
Goldberg, RL
Becker, KL
机构
[1] Vet Affairs Med Ctr, Surg Serv, Washington, DC 20422 USA
[2] Vet Affairs Med Ctr, Med Serv, Surg Intens Care Unit, Washington, DC 20422 USA
[3] Georgetown Univ, Washington, DC 20422 USA
[4] George Washington Univ, Washington, DC 20422 USA
关键词
D O I
10.1210/jc.83.9.3296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High serum levels of the calcitonin (CT) prohormone, procalcitonin (pro-CT), and its component peptides occur in systemic inflammation and sepsis. Using two different assays, we undertook a prospective study to determine the utility of serum precalcitonin peptides (pre-CT) as markers in this condition. Twenty-nine patients meeting criteria for the systemic inflammatory response syndrome were studied daily in two intensive care units. Sera mere collected, and APACHE II scores were determined until recovery or death. All patients had markedly elevated serum pre-CT. Prognostically, peak values were the most important. The highest values portended mortality, and a lower level could be ascertained below which all patients survived. Peak pre-CT levels were significantly higher in patients with infection documented by blood cultures than in those patients with no documented infection from any source (P < 0.05). Mature CT remained normal or only moderately elevated. Compared with the serum pre-CT levels, receiver operating characteristic curve analysis revealed that the APACHE II scores, although more cumbersome, were better overall predictors of mortality. Thus, pre-CT is an important serum marker for systemic inflammatory response syndrome and is predictive of outcome. It also provides data concerning the presence of severe infection and may prove to be clinically useful for proactive patient care.
引用
收藏
页码:3296 / 3301
页数:6
相关论文
共 23 条
  • [1] Al-Nawas B, 1996, Eur J Med Res, V1, P331
  • [2] HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION
    ASSICOT, M
    GENDREL, D
    CARSIN, H
    RAYMOND, J
    GUILBAUD, J
    BOHUON, C
    [J]. LANCET, 1993, 341 (8844) : 515 - 518
  • [3] Becker Kenneth L., 1996, P471
  • [4] CALCITONIN IN EXTRA-THYROIDAL TISSUES OF MAN
    BECKER, KL
    SNIDER, RH
    MOORE, CF
    MONAGHAN, KG
    SILVA, OL
    [J]. ACTA ENDOCRINOLOGICA, 1979, 92 (04): : 746 - 751
  • [5] BECKER KL, 1980, ARCH PATHOL LAB MED, V104, P196
  • [6] THE PATHOGENESIS OF SEPSIS
    BONE, RC
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) : 457 - 469
  • [7] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [8] HYPERCALCITONINEMIA IN ACUTE-PANCREATITIS
    CANALE, DD
    DONABEDIAN, RK
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 40 (04) : 738 - 741
  • [9] CHESNEY RW, 1983, J LAB CLIN MED, V101, P576
  • [10] EFFECT OF CALCITONIN ON THE INTERDIGESTIVE MOTILITY AND ON GASTRIC AND PANCREATIC-SECRETION IN HUMANS
    DEMOL, P
    HOTZ, J
    MULLER, MK
    TROMPETER, R
    MUTTATHIL, J
    GOEBELL, H
    [J]. ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1986, 94 (05): : 331 - 338